Category: Home

Copper and iron metabolism

Copper and iron metabolism

The metabolosm Copper and iron metabolism of Cpper patients Whole Grain Selection Increased glucose disposal ketabolism AMP-dependent kinase signaling in a mouse model of hemochromatosis. Annd was hypothesized irpn this Copper and iron metabolism could result Copper and iron metabolism defective iron mobilization due to decreased Iroon activity, yet individuals with inherited aceruloplasminemia do not always develop overt anemia We recently reported low intrahepatic copper concentrations in human NAFLD compared to other liver diseases and that rats on a copper depleted diet developed IR and liver steatosis[ ]. As a result, copper deficiency could make you feel cold. Viewpoint Collections In-Press Preview Commentaries Research Letters Letters to the Editor Editorials Viewpoint JCI This Month Top read articles Clinical Medicine.

Copper and iron metabolism -

Light mucosal scrapes of freshly harvested intestinal tissue were collected for RNA isolation, or enterocytes were isolated as previously described [21].

Enterocyte iron and copper content was determined by ICP-MS Michigan State Univ. Serum and liver copper and iron concentrations were measured in-house by flame atomic absorption spectrometery AAS , using standard protocols.

Blood samples were incubated at 4°C for 4 hrs, and then serum was obtained by centrifugation at g for 10 min. Total RNA was isolated from intestinal and liver tissue by Trizol reagent, and SYBR-Green qRT-PCR was performed by well-established methods [9] , [22].

Primers listed in Table S1 were designed to span large introns to eliminate amplification from genomic DNA.

Each primer pair was independently validated by initially performing standard curve reactions over a series of cDNA dilutions; linear amplification was noted in each case. Furthermore, melt curves routinely showed single amplicons.

Mouse cyclophilin mRNA expression was used to normalize expression levels of experimental genes. Mean fold-change of mRNA levels from all experimental groups i. Body iron utilization in mice was determined by gavage with 59 Fe, essentially as described [24].

Briefly, mice were fasted overnight but allowed free access to water ad libitum prior to gavage feeding of 59 Fe-HCl µCi; 1. Mice were subsequently fasted for 7 hr and then given free access to chow. Radioactivity in the whole carcass and blood were initially measured by gamma counting whole body radioactivity , followed by excising tissues and measuring radioactivity in liver and spleen.

Serum ferroxidase activity ferrozine was determined as previously described [15]. As iron is oxidized, fluorescence intensity thus decreases i. a substrate disappearance assay.

In all assays, data were corrected for background absorbance of a reference solution all components without the serum sample , thus controlling for auto-oxidation of ferrous iron.

Oxidase activity is presented as changes in A Δ A in comparison to the reference solution. Reciprocal values of data were calculated, so plots are shown as increasing over time, which was intended to increase clarity.

Except for using some heterozygous females for breeding, WT females and excess WT males were routinely sacrificed in the perinatal period. Within 24 hours of injection, strikingly, grey colored hair growth occurred mutant mice were initially pinkish Fig.

The changes were even more dramatic after the 2 nd copper injection Fig. A lesion was noted on the upper back marking the site of injection, which gradually became less distinct and was hardly noticeable 10 weeks later panel E.

Mice were photographed before and after copper treatment to exemplify the dramatic phenotypical changes that occur in the mutants. A 7-day-old male mice prior to treatment. Mutant males are pink. B 8-day-old mice after first Cu injection. C 9-day-old mice after second Cu injection. D 3-month-old WT male.

Iron levels were determined as described in Methods. Results are depicted graphically, with filled bars representing data from mice fed the control diet and open bars depicting data from FeD mice.

Genotype is indicated beneath each bar. Iron levels were normalized by mass of tissue or volume of serum. Also depicted is hepatic Hamp mRNA expression D , normalized to cyclophilin mRNA levels which did not vary significantly.

WT, wild-type. Bars A—D depict mean±SD. Expression of Cybrd1, Dmt1, Fpn1, Tfr1 and Atp7a increased in both genotypes upon dietary iron deprivation in duodenum samples from experimental animals Fig. Fold increases however did not achieve statistically significant differences between genotypes.

Expression of ferritin Ftn , Heph and copper transporter 1 Ctr1 mRNA was not different between genotypes or dietary groups data not shown.

Expression of key genes indicated in each panel was determined by standard methods, with each experimental gene being normalized to expression of mouse cyclophilin mRNA which did not vary significantly. Filled bars represent data from mice fed the control diet and open bars represent data from mice consuming the low-iron diet.

Genotype is indicated below each bar. Bars A—F depict mean±SD. Moreover, expression of two known hypoxia-responsive genes, Ankrd37 and Bnip3 were upregulated in all mice that had low circulating hemoglobin levels i. Furthermore, hepatic expression of ceruloplasmin Cp , Dmt1 and Fpn1 was not significantly different amongst all groups of mice data not shown.

Bars A—C depict mean±SD. Copper levels were determined as described in Methods A—C. Copper levels were normalized by mass of tissue or volume of serum. Also depicted is quantification of serum FOX activity D—F , as determined by ferrozine assay. In mice used for iron uptake studies, Hb and Hct levels showed similar reductions to data presented in Table 1 Fig.

Mice that were concurrently bled however displayed more significant Hb and Hct reductions. Mice were fed a control diet or an iron-deficient diet for three weeks with or without concurrent once weekly bloodletting.

Subsequently, 59 Fe was administered by oral gavage and the distribution of radioactivity was assessed 24 hours later. In all panels, the left side depicts data from dietary iron deprivation only, while the right panel shows data from dietary iron deprivation plus bleeding.

Each bar is defined in panel A, and is consistent throughout all panels. Genotypes are indicated below each bar. Bars A—E depict mean±SD. Although copper homeostasis has been thoroughly examined in Brindled mice as cited above , to our knowledge, iron homeostasis has not been investigated.

Suckling mice were previously injected with iron and compared to copper injection and killed a few days later for analysis [26] , [27] ; however, mechanisms of absorption are different in neonatal mice, likely involving non-specific nutrient absorption via pinocytosis and para -cellular flux [20].

Brindled mice die perinatally of severe copper deficiency [19] , [28]. Copper-treated, mutant mice developed and grew normally but still had persistent perturbations in body copper levels; 53 days post-injection, Cu levels in kidney were high and levels were low in brain and serum [12].

We treated mice twice with copper chloride in the perinatal period, allowed mice to recover for 7—8 weeks and then deprived them of dietary iron. Earlier studies treated WT mice with copper, and although liver copper levels were very high 11 days post-injection 7× higher than untreated controls , they had normalized 2 weeks later [12] , and no other persistent perturbations in copper levels were noted.

Furthermore, although the copper treatment likely produced an acute inflammatory response, when mice were studied at weeks-of-age, there was no sign of inflammation, as exemplified by normal hepatic hepcidin Hamp mRNA expression. Hamp is known to be strongly induced at the transcriptional level by pro-inflammatory cytokines e.

IL-6 [30] , and as such, Hamp gene expression levels serve as a sensitive marker of the acute-phase response. The mutant mice did however have perturbations in body copper levels including decreased hepatic and serum copper, indicative of severe systemic copper deficiency see Table S2 for a comprehensive overview of all data from this study.

Low hepatic copper levels have been noted in Brindled mice [31] , although this is thought to be a secondary phenomenon related to copper being avidly taken up by and trapped within other tissues [19]. Serum FOX i. Cp activity was also reduced in the rescued mutants, consistent with previous observations.

serum FOX activity Fig. This is consistent with our previous observations in rats consuming various iron- and copper-deficient diets [15]. Given the documented role of Cp in iron release from liver and other tissues [32] , it is not readily apparent why liver iron levels were not increased in the mutant mice.

In sum, these observations demonstrated that copper-treated, Brindled mice suffered from copper-deficiency anemia, displaying many known symptoms of copper deprivation in mice [33]. Interestingly, this is in contrast to phenotypical changes associated with copper deficiency in other mammalian species, including swine, rats and humans [34] — [36] , in which perturbations in iron homeostasis are noted.

The main goal of this investigation was to define the role of Atp7a and copper in the compensatory response of the intestinal epithelium to iron deprivation. Accordingly, iron absorption studies were performed in all experimental mice, including WT, iron-deficient FeD WT, Brindled and FeD Brindled mice.

FeD WT mice had the classical iron-deficient phenotype. Although body copper levels were not altered in the FeD WT mice, as is commonly noted in other mammalian species e. human, rat etc. As expected, iron absorption in WT FeD mice was significantly enhanced by iron deprivation and was further increased by concurrent phlebotomy.

The mutants consuming a standard chow diet were copper deficient, but had no observable perturbations in iron homeostasis, in contrast to previous studies on dietary copper deficiency in mice [37] , [38] and rats [39] , in which hypoferremia was noted.

Past studies have provided conflicting results in regards to iron homeostasis in the setting of dietary copper deprivation in mice [41] — [43]. Dmt1, Fpn1, Atp7a were not induced. Known hypoxia-responsive genes were indeed induced in liver of the mutant mice Ankrd37 [44] , Bnip3 [45] , consistent with decreased blood hemoglobin levels and tissue hypoxia.

These observations suggest that the signal for Hif2α-mediated induction of iron and copper homeostasis-related genes in mice is low intracellular iron, as hypoxia in the setting of normal intracellular iron levels did not trigger the response. This possibility would however have to be experimentally verified before definitive conclusions could be drawn.

Of further note is the fact that although circulating FOX i. This is in contrast to the reported Hif1α-mediated transcriptional induction of the Cp promoter in HepG2 cells [49] , but is consistent with our previous study in rats in which iron deprivation increased hepatic Cp protein expression and serum Cp activity without effect on Cp mRNA expression [15].

Thus, in vivo upregulation of Cp in rats and mice during iron-deficiency anemia and hypoxia likely does not involve HIF signaling in the liver. This exemplifies a perhaps unique aspect of iron homeostasis in this strain of mice, as altered copper homeostasis typifies iron deficiency in humans and other mammalian species.

Conversely, in the same strain of mice harboring a 6 bp deletion in the Atp7a gene, enhanced iron absorption upon iron deprivation was associated with increased enterocyte and hepatic copper levels and serum FOX activity.

Question 2 has two possible explanations, first that residual Atp7a function could explain increased hepatic copper levels, or secondly that hepatic copper loading is independent of copper absorption and relates to altered copper excretion, as mediated by the Atp7b copper-transporting ATPase expressed on the canicular surface of hepatocytes.

Although definitive answers to these puzzling questions await further experimentation, these novel studies provide additional support of the concept that copper plays an important role in the maintenance of mammalian iron homeostasis.

Relative Cp activity as a function of serum and liver copper levels. Copper helps ensure healthy thyroid hormone levels. These hormones help regulate your metabolism and body heat.

As a result, copper deficiency could make you feel cold. People with lighter skin usually have fewer, smaller and lighter melanin pigments than people with darker skin Interestingly, copper is used by enzymes that produce melanin.

Therefore, copper deficiency could affect the production of this pigment, causing pale skin 30 , However, more human-based research investigating the link between pale skin and copper deficiency is needed.

Copper is used by enzymes that make melanin, the pigment that determines skin color. Copper deficiency may cause pale skin. Given that low copper levels can affect melanin formation, copper deficiency may cause premature gray hair 32 , While there is some research on copper deficiency and melanin pigment formation, hardly any studies have looked at the link between copper deficiency and gray hair specifically.

More human-based research in this area would help clarify the link between the two. Like skin color, hair color is affected by melanin, which requires copper.

This means copper deficiency may promote premature gray hair. Vision loss is a serious condition that may occur with long-term copper deficiency 34 , Copper is used by many enzymes that help ensure the nervous system works properly.

This means that copper deficiency can cause problems with the nervous system, including vision loss It seems that vision loss due to copper deficiency is more common among people who have had surgery on their digestive tract, such as gastric bypass surgery.

While there is some evidence that vision loss caused by copper deficiency is reversible, other studies have shown no vision improvement after increasing copper intake 34 , Copper deficiency may cause vision loss.

This is because your vision is closely linked to your nervous system, which relies heavily on copper. In addition, you only need a small amount of copper to meet the recommended daily intake RDI of 0. The following foods are excellent sources of copper 39 :.

Simply eating some of these foods throughout the week should provide you with enough copper to maintain healthy blood levels. That said, the amount of copper found in tap water is very small, so you should eat a variety of copper-rich foods. Copper is found in many staple foods, which is why deficiency is rare.

Eating a balanced diet should help you meet the recommended daily amount. Copper toxicity can have unpleasant and potentially fatal side effects, including 40 , 41 :.

While copper toxicity is rare, the side effects can be very dangerous. They will see if you are at risk of copper deficiency and may test your blood copper levels.

Simply consuming a balanced diet should help you meet your daily copper needs. Common signs and symptoms of copper deficiency include fatigue and weakness, frequent sickness, weak and brittle bones, problems with memory and learning, difficulties walking, increased cold sensitivity, pale skin, premature gray hair and vision loss.

Our experts continually monitor the health and wellness space, and we update our articles when new information becomes available. Vitamin C deficiency is rare, but there are some subtle signs to watch out for. Here are the 15 most common signs and symptoms of vitamin C deficiency.

While vitamin A deficiency is rare in developed countries, certain people may be at a higher risk. Here are 8 signs and symptoms of vitamin A…. Let's look at symptoms of copper toxicity, the most likely sources of exposure to this metal, and what you can do to prevent your exposure to high….

Here is a detailed review of 8 nutrients that can help maintain proper eye function, protect your eyes from damage and fight the negative effects of…. Ahmed U , Latham PS, Oates PS. Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis.

Zelber-Sagi S , Nitzan-Kaluski D, Halpern Z, Oren R. NAFLD and hyperinsulinemia are major determinants of serum ferritin levels. J Hepatol. Fargion S , Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, Taioli E, Valenti L, Fiorelli G. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis.

Am J Gastroenterol. Fargion S , Dongiovanni P, Guzzo A, Colombo S, Valenti L, Fracanzani AL. Iron and insulin resistance. Aliment Pharmacol Ther. George DK , Goldwurm S, MacDonald GA, Cowley LL, Walker NI, Ward PJ, Jazwinska EC, Powell LW.

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

Fierbinţeanu-Braticevici C , Bengus A, Neamţu M, Usvat R. The risk factors of fibrosis in nonalcoholic steatohepatitis. Rom J Intern Med. Bhattacharya R , Kowdley KV. Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime?

Chitturi S , Weltman M, Farrell GC, McDonald D, Kench J, Liddle C, Samarasinghe D, Lin R, Abeygunasekera S, George J. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with CY but not with fibrotic severity.

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatic iron and nonalcoholic fatty liver disease. Kowdley KV , Belt P, Wilson LA, Yeh MM, Neuschwander-Tetri BA, Chalasani N, Sanyal AJ, Nelson JE.

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Maliken BD , Nelson JE, Klintworth HM, Beauchamp M, Yeh MM, Kowdley KV.

Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease. Nelson JE , Brunt EM, Kowdley KV. Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with CY HFE mutations.

Raszeja-Wyszomirska J , Kurzawski G, Lawniczak M, Miezynska-Kurtycz J, Lubinski J. Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study. Valenti L , Dongiovanni P, Fracanzani AL, Fargion S. HFE mutations in nonalcoholic fatty liver disease. Valenti L , Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G, Marchesini G.

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Valenti L , Canavesi E, Galmozzi E, Dongiovanni P, Rametta R, Maggioni P, Maggioni M, Fracanzani AL, Fargion S.

Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease. Valenti L , Rametta R, Dongiovanni P, Motta BM, Canavesi E, Pelusi S, Pulixi EA, Fracanzani AL, Fargion S. The AV TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease.

PLoS One. Valenti L , Dongiovanni P, Piperno A, Fracanzani AL, Maggioni M, Rametta R, Loria P, Casiraghi MA, Suigo E, Ceriani R. Alpha 1-antitrypsin mutations in NAFLD: high prevalence and association with altered iron metabolism but not with liver damage.

Adams LA , Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Weismüller TJ , Kirchner GI, Scherer MN, Negm AA, Schnitzbauer AA, Lehner F, Klempnauer J, Schlitt HJ, Manns MP, Strassburg CP.

Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long-term recipient survival.

Walker NM , Stuart KA, Ryan RJ, Desai S, Saab S, Nicol JA, Fletcher LM, Crawford DH. Serum ferritin concentration predicts mortality in patients awaiting liver transplantation. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.

Dmochowski K , Finegood DT, Francombe W, Tyler B, Zinman B. Factors determining glucose tolerance in patients with thalassemia major.

J Clin Endocrinol Metab. Frayling T , Ellard S, Grove J, Walker M, Hattersley AT. CY mutation in HFE haemochromatosis gene and type 2 diabetes. Merkel PA , Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, Tamborlane WV. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.

Abraham D , Rogers J, Gault P, Kushner JP, McClain DA. Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis.

McClain DA , Abraham D, Rogers J, Brady R, Gault P, Ajioka R, Kushner JP. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Huang J , Gabrielsen JS, Cooksey RC, Luo B, Boros LG, Jones DL, Jouihan HA, Soesanto Y, Knecht L, Hazel MW.

Increased glucose disposal and AMP-dependent kinase signaling in a mouse model of hemochromatosis. Furukawa S , Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I.

Increased oxidative stress in obesity and its impact on metabolic syndrome. Urakawa H , Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y. Oxidative stress is associated with adiposity and insulin resistance in men.

Houstis N , Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Tan TC , Crawford DH, Jaskowski LA, Subramaniam VN, Clouston AD, Crane DI, Bridle KR, Anderson GJ, Fletcher LM.

Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury. Lab Invest. van de Wier B , Balk JM, Haenen GR, Giamouridis D, Bakker JA, Bast BC, den Hartog GJ, Koek GH, Bast A. Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production.

FEBS Lett. Sutti S , Jindal A, Locatelli I, Vacchiano M, Gigliotti L, Bozzola C, Albano E. Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH.

Dongiovanni P , Valenti L, Ludovica Fracanzani A, Gatti S, Cairo G, Fargion S. Iron depletion by deferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. Am J Pathol. Datz C , Felder TK, Niederseer D, Aigner E.

Iron homeostasis in the metabolic syndrome. Carter R , Mouralidarane A, Soeda J, Ray S, Pombo J, Saraswati R, Novelli M, Fusai G, Rappa F, Saracino C.

Non-alcoholic fatty pancreas disease pathogenesis: a role for developmental programming and altered circadian rhythms. Cho H , Zhao X, Hatori M, Yu RT, Barish GD, Lam MT, Chong LW, DiTacchio L, Atkins AR, Glass CK.

Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. Green A , Basile R, Rumberger JM. Transferrin and iron induce insulin resistance of glucose transport in adipocytes. Rumberger JM , Peters T, Burrington C, Green A. Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes.

Aso Y , Takebayashi K, Wakabayashi S, Momobayashi A, Sugawara N, Terasawa T, Naruse R, Hara K, Suetsugu M, Morita K. Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes.

Diabetes Res Clin Pract. Ku BJ , Kim SY, Lee TY, Park KS. Serum ferritin is inversely correlated with serum adiponectin level: population-based cross-sectional study.

Dis Markers. Gabrielsen JS , Gao Y, Simcox JA, Huang J, Thorup D, Jones D, Cooksey RC, Gabrielsen D, Adams TD, Hunt SC. Adipocyte iron regulates adiponectin and insulin sensitivity. Dongiovanni P , Fracanzani AL, Fargion S, Valenti L. Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target.

Fernández-Real JM , Moreno JM, Chico B, López-Bermejo A, Ricart W. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance.

Fernández-Real JM , Moreno JM, Ricart W. Circulating retinol-binding protein-4 concentration might reflect insulin resistance-associated iron overload. Wouters K , van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D, Kerksiek A, van Kruchten R, Maeda N, Staels B.

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.

Ikura Y , Ohsawa M, Suekane T, Fukushima H, Itabe H, Jomura H, Nishiguchi S, Inoue T, Naruko T, Ehara S. Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. Nairz M , Schroll A, Demetz E, Tancevski I, Theurl I, Weiss G.

Hemochromatosis: an endocrine liver disease. Weiss G , Schett G. Anaemia in inflammatory rheumatic diseases. Nat Rev Rheumatol. Sonnweber T , Nachbaur D, Schroll A, Nairz M, Seifert M, Demetz E, Haschka D, Mitterstiller AM, Kleinsasser A, Burtscher M.

Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB. Hou Y , Zhang S, Wang L, Li J, Qu G, He J, Rong H, Ji H, Liu S. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element.

Goodnough JB , Ramos E, Nemeth E, Ganz T. Inhibition of hepcidin transcription by growth factors. Latour C , Kautz L, Besson-Fournier C, Island ML, Canonne-Hergaux F, Loréal O, Ganz T, Coppin H, Roth MP.

Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Harrison-Findik DD , Schafer D, Klein E, Timchenko NA, Kulaksiz H, Clemens D, Fein E, Andriopoulos B, Pantopoulos K, Gollan J.

Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. Barisani D , Pelucchi S, Mariani R, Galimberti S, Trombini P, Fumagalli D, Meneveri R, Nemeth E, Ganz T, Piperno A. Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload.

Détivaud L , Nemeth E, Boudjema K, Turlin B, Troadec MB, Leroyer P, Ropert M, Jacquelinet S, Courselaud B, Ganz T. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function.

Lainé F , Deugnier Y. Increased expression of hepcidin in obese patients: impact on phenotypic expression of hemochromatosis and pathophysiology of dysmetabolic iron overload syndrome.

Dallalio G , Law E, Means RT. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Weiss G , Goodnough LT. Anemia of chronic disease.

Huang J , Simcox J, Mitchell TC, Jones D, Cox J, Luo B, Cooksey RC, Boros LG, McClain DA. Iron regulates glucose homeostasis in liver and muscle via AMP-activated protein kinase in mice. FASEB J. Chung B , Matak P, McKie AT, Sharp P.

Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr. Amato A , Santoro N, Calabrò P, Grandone A, Swinkels DW, Perrone L, del Giudice EM.

Effect of body mass index reduction on serum hepcidin levels and iron status in obese children. Int J Obes Lond. Aigner E , Theurl I, Haufe H, Seifert M, Hohla F, Scharinger L, Stickel F, Mourlane F, Weiss G, Datz C. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.

Zoller H , Koch RO, Theurl I, Obrist P, Pietrangelo A, Montosi G, Haile DJ, Vogel W, Weiss G. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Ruivard M , Lainé F, Ganz T, Olbina G, Westerman M, Nemeth E, Rambeau M, Mazur A, Gerbaud L, Tournilhac V.

Iron absorption in dysmetabolic iron overload syndrome is decreased and correlates with increased plasma hepcidin. Zimmermann MB , Zeder C, Muthayya S, Winichagoon P, Chaouki N, Aeberli I, Hurrell RF. Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification.

Sonnweber T , Ress C, Nairz M, Theurl I, Schroll A, Murphy AT, Wroblewski V, Witcher DR, Moser P, Ebenbichler CF. High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption.

Otogawa K , Kinoshita K, Fujii H, Sakabe M, Shiga R, Nakatani K, Ikeda K, Nakajima Y, Ikura Y, Ueda M. Erythrophagocytosis by liver macrophages Kupffer cells promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis.

Davis RJ , Corvera S, Czech MP. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. Yokomori N , Iwasa Y, Aida K, Inoue M, Tawata M, Onaya T. Transcriptional regulation of ferritin messenger ribonucleic acid levels by insulin in cultured rat glioma cells.

Klevay LM. Is the Western diet adequate in copper? J Trace Elem Med Biol. al-Othman AA , Rosenstein F, Lei KY. Copper deficiency alters plasma pool size, percent composition and concentration of lipoprotein components in rats.

Copper deficiency increases in vivo hepatic synthesis of fatty acids, triacylglycerols, and phospholipids in rats. Proc Soc Exp Biol Med.

Aigner E , Strasser M, Haufe H, Sonnweber T, Hohla F, Stadlmayr A, Solioz M, Tilg H, Patsch W, Weiss G. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease. Prohaska JR , Geissler J, Brokate B, Broderius M.

Copper, zinc-superoxide dismutase protein but not mRNA is lower in copper-deficient mice and mice lacking the copper chaperone for superoxide dismutase. Exp Biol Med Maywood.

Schuschke DA , Adeagbo AS, Patibandla PK, Egbuhuzo U, Fernandez-Botran R, Johnson WT. Cyclooxygenase-2 is upregulated in copper-deficient rats. Wei YZ , Rector RS, Thyfault JP, Ibdah JA.

Nonalcoholic fatty liver disease and mitochondrial dysfunction. Song M , Schuschke DA, Zhou Z, Chen T, Pierce WM, Wang R, Johnson WT, McClain CJ. High fructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanism for obesity related fatty liver.

Chung J , Haile DJ, Wessling-Resnick M. Copper-induced ferroportin-1 expression in J macrophages is associated with increased iron efflux. Proc Natl Acad Sci USA. De Domenico I , Ward DM, di Patti MC, Jeong SY, David S, Musci G, Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin.

EMBO J. Musci G , Polticelli F, Bonaccorsi di Patti MC. Ceruloplasmin-ferroportin system of iron traffic in vertebrates. World J Biol Chem.

Levi S , Finazzi D. Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms.

Front Pharmacol. Piperno A , Vergani A, Salvioni A, Trombini P, Viganò M, Riva A, Zoppo A, Boari G, Mancia G. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome.

Liver Int. Facchini FS. Effect of phlebotomy on plasma glucose and insulin concentrations. Nitenberg A , Ledoux S, Valensi P, Sachs R, Antony I. Coronary microvascular adaptation to myocardial metabolic demand can be restored by inhibition of iron-catalyzed formation of oxygen free radicals in type 2 diabetic patients.

Lorraine GamblingMetablism S. Andersen annd, Copper and iron metabolism J. McArdle; Iron and copper, Copper and iron metabolism their interactions during development. Biochem Cognitive skills improvement Trans 1 December ; 36 6 : — During development, the fetus is entirely dependent on the mother for its nutrient requirements. Subsequently, it is a period when both are vulnerable to changes in dietary supply, especially of those nutrients that are marginal under normal circumstances. Copper Cu is an essential trace element for humans and other mammals. The metabolksm properties of copper underlie its mtabolism role in oxidation Herbal Blood Pressure Support reduction reactions and in Coppee free Copper and iron metabolism 1. Metabollism Copper and iron metabolism an said andd have prescribed copper Copper and iron metabolism to treat diseases irpn early as B. Copper ,etabolism critical for the function of several essential enzymes known as cuproenzymes, which are integral parts of various metabolic pathways 4, 5. Physiologic functions of these copper-dependent enzymes, and the biochemical pathways in which they function 6, 7are outlined below. The copper-dependent enzyme cytochrome c oxidase CCO plays a critical role in cellular energy production in mitochondria by catalyzing the reduction of molecular oxygen O 2 to water H 2 Othereby generating an electrical gradient that is required for ATP production 8. Redox-active copper contained within the CCO enzyme complex is required for the electron transfer reactions that are critical for its function. Copper and iron metabolism


7. COPPER- Sources, RDA, Functions, diseases related to copper

Author: Dihn

4 thoughts on “Copper and iron metabolism

Leave a comment

Yours email will be published. Important fields a marked *

Design by